With the World Health Organisation recently declaring the Zika virus the latest international public health emergency, pressure is growing on pharmaceutical manufacturers to rapidly increase production in order to meet spikes in demand.

Leading global asset management specialist, EquipNet Inc., has witnessed an increase in the number of pharma businesses purchasing pre-owned assets from other top-tier manufacturers to upscale production, as they realise the substantial time and cost savings that can be made. 

Ben Potenza, Vice President of Marketing at EquipNet, comments, “Pre-owned equipment is generally available immediately and delivery can be made as soon as a purchase is completed, which is something that can not always be guaranteed when purchasing a new system.”

With the prefilled syringe market set to grow with a CAGR of 12.9%* between 2015-2020, the need for pharmaceutical manufacturers to increase productivity levels and reduce time to market, is greater than ever before. This is where the option to purchase second user equipment can be extremely appealing as the process offers two key benefits for purchasers – cost savings and quick availability.

“In today’s rapidly evolving market, pharmaceutical companies’ needs change and we are increasingly selling equipment that has never been used before in production. Take the example of one of our new online additions – an unused Optima Sterile Syringe Filling Line. This option is ideal for companies who are in urgent need of equipment to upscale production of prefilled syringes to address the growing global requirement for safe and convenient delivery of drugs such as vaccines.” Comments Ben.

With a growing number of businesses joining the second-user equipment revolution, identifying a reliable partner, with industry knowledge can be critical to success in this field. 

more about equipnet